Endothelial Dysfunction Linked to Ventricular Dysfunction in Children With Sickle Cell Disease, a 3D Speckle Tracking

Antoine AbdelMassih1, Mervat Haroun2, Rasha AbdelRaouf AbdelAziz Afifi3

  • 1Pediatric Cardiology Unit, Department of Pediatrics, Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.

Insights

Vascular stiffness contributes to left ventricular dysfunction in Sickle Cell Disease (SCD). Reduced Nitric Oxide (NO) levels are linked to endothelial dysfunction, highlighting a potential therapeutic target for SCD complications.

Area of Science:

  • Cardiology
  • Hematology
  • Vascular Biology

Background:

  • Sickle Cell Disease (SCD) is a multi-organ disease with growing evidence linking vascular stiffness to its complications.
  • Endothelial dysfunction and depletion of vasodilators like Nitric Oxide (NO) are implicated in SCD pathophysiology.

Purpose of the Study:

  • To investigate the relationship between endothelial stiffness and left ventricular (LV) dysfunction in SCD patients.
  • To explore the role of NO depletion in the pathophysiology of endothelial dysfunction in SCD.

Main Methods:

  • A case-control study involving 32 SCD patients and 40 healthy controls.
  • Assessment of endothelial function via Brachial Flow-mediated dilation (FMD) and serum NO levels.
  • Echocardiographic assessment using 3D speckle tracking echocardiography (STE) and tissue Doppler imaging (TDI).

Main Results:

  • SCD patients exhibited systolic-diastolic dysfunction and reduced FMD, indicating endothelial dysfunction.
  • Significantly lower serum NO levels and elevated LDH were observed in SCD patients compared to controls.
  • A positive correlation was found between FMD, ventricular dysfunction, and serum NO levels, confirming NO's role.

Conclusions:

  • This study is the first to link vascular stiffness, measured by FMD, to LV dysfunction in SCD.
  • Strategies to replenish NO stores may help delay microvascular injury and ventricular dysfunction in SCD.
Abstract